Landon L. Chan
Chinese University of Hong Kong(HK)Prince of Wales Hospital(CN)University of Hong Kong(HK)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Lung Cancer Treatments and Mutations, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways(2015)306 cited
- → Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation(2014)192 cited
- → Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants(2012)156 cited
- → Supervised enhancer prediction with epigenetic pattern recognition and targeted validation(2020)117 cited
- → The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment(2025)61 cited
- → Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond(2022)52 cited